MIRA INFORM REPORT

 

 

Report Date :

03.09.2014

 

IDENTIFICATION DETAILS

 

Name :

ENALTEC LABS PRIVATE LIMITED

 

 

Registered Office :

1706, 17th Floor, Kesar Solitaire, Plot No.5, Sector – 19, Sanpada, Navi Mumbai 400705, Maharashtra 

 

 

Country :

India

 

 

Financials (as on) :

31.03.2013

 

 

Date of Incorporation :

24.02.2006

 

 

Com. Reg. No.:

11-160020

 

 

Capital Investment / Paid-up Capital :

Rs.15.477 Millions

 

 

CIN No.:

[Company Identification No.]

U73100MH2006PTC160020

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUME06806C

 

 

PAN No.:

[Permanent Account No.]

AABCE5821H

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturing and Trading in of Pharmaceuticals Products.

 

 

No. of Employees :

Information denied by management

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (48)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 1200000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually Correct 

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having satisfactory track record.

 

The rating reflects company’s sound financial risk profile supported by diversified product portfolio and decent profitability levels of the company.

 

Trade relations are fair. Business is active. Payment terms are reported to be usually correct.

 

The company can be considered for business dealings at usual trade terms and conditions.    

 

NOTES:

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – June 1, 2014

 

Country Name

Previous Rating

(31.03.2014)

Current Rating

(01.06.2014)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

N E W S

 

As per the latest IMF study, the total weigh of emerging markets in the GDP of the world on a purchasing power parity basis has seen a sizeable shift. It highlights how as against 51 % in 2005, the emerging economies now account for close to 56 % of the global purchasing power GDP as per the latest survey. And with the emerging economies growing at a faster rate than their developed counterparts, there are every possibility that the their share goes up further in the coming years.  China may surpass the US over the next few years.

 

Politics and economics are very intricately connected. They tend to influence each other in ways that could be very complex and far-reaching. The prospects of the India’s economy have been seriously compromised due to political corruption. High inflation, poor standard of living are to a great extent a result of rampant corruption in the country. China on the other hand, seems to be facing diametrically opposite challenge. American hedge fund manager Jim Chanos has been keenly following the political and economic development in the dragon economy and has figured out something that is quite worrying. He is of the view that the Chinese economy could be heading toward trouble on account of new Chinese President Xi Jingping’s very aggressive anti-corruption drive. Chanos believes tat many things such as apartment sales, luxury products, etc. were largely bought with dirty money. And it is now beginning to impact consumption. This may indeed be bad news for an economy that is struggling to transition from an investment-driven export-oriented economy to a domestic consumption-driven economy.

 

A study published by Firstpost has revealed that asset classes like real estate and equities were the biggest beneficiaries of the liberalization policies.  A firm called Ciane Analytics studied returns from assets including equities, gold, fixed deposits, G-Secs and real estate since 1991. Real estate outperformed every other asset classes during the 23-year period with an annualized return of 20 % ! Equities came in second with annualized return of 15.5 % ! However, while these returns may seem mouthwatering, the fact is that the return from equities adjusted for inflation came down to just 7.1 %.

Some brief news are as under

 

. R-Power to buy Jaypee’s hydro assets

. Investors await justice in NSEL case

. India seeks MFN status from Pakistan ahead of meeting

. Ukrain’s clashes with rebels hinder MH17 crash investigation

. India exploring merger of state-owned hydro PSUs

..Higher costs weigh down profit growth to slowest in 9 quarters

..Wal-Mart to expand wholesale business in India

. GMR group moves to strengthen balance sheet

. Central Bank to sell 4 % stake to Life Insurance Corporation

. Tata Chemicals plans to raise up to Rs 10000 mn.

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CARE

Rating

Long Term Bank Facilities = BBB

Rating Explanation

Moderate degree of safety and moderate credit risk 

Date

12.09.2013

 

 

Rating Agency Name

CARE

Rating

Short Term Bank Facilities = A3

Rating Explanation

Moderate degree of safety and high credit risk. 

Date

12.09.2013

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2014.

 

 

INFORMATION DENIED BY

 

Name :

Mr. Kaushik Dedhiya

Designation :

Finance Head

Contact No.:

91-22-67507000

Date :

01.09.2014

 

 

LOCATIONS

 

Registered Office :

1706, 17th Floor, Kesar Solitaire, Plot No.5, Sector – 19, Sanpada, Navi Mumbai 400705, Maharashtra, India

Tel. No.:

91-22-41707000

Fax No.:

91-22-41707070

E-Mail :

info@enalteclabs.co.in

shetty_02@rediffmail.com

sbi.06240@sbi.co.in

anand.shah@enalteclabs.co.in 

Website :

http://www.enalteclabs.co.in

 

 

Factory 1 :

Plot No. N-61, MIDC, Additional Ambernath, District Thane, Mumbai – 421506, Maharashtra, India

 

 

Factory 2 :

Gat No.204, Nashik-Mumbai Highway, Vadicarhe, Taluka Igatpuri, District Nashik – 422403, Maharashtra, India 

 

 

Research Lab / R and D Centre :

W – 59 A, Additional Ambernath Industrial Area, Anand Nagar, Ambernath (East), Mumbai – 421501, Maharashtra, India

 

 

DIRECTORS

 

As on 11.09.2013

 

Name :

Mr. Anand Prafulchandra Shah

Designation :

Managing Director

Address :

Flat 1204/1205/1206, Bldg 3, Odyssey Kesar, Harmony Plot 11/12, Sector - 6, Kharghar, Mumbai, 410 210, Maharashtra, India

Date of Birth/Age :

09.03.1973

Date of Appointment :

23.12.2013

DIN No.:

00597145

Other Directorship:

S.

No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24230MH2004PTC146489

PHARMA SERV SOLUTIONS PRIVATE LIMITED

Director

24/05/2004

24/05/2004

03/12/2009

Active

NO

2

U24230MH2005PTC153404

GETZ PHARMA RESEARCH PRIVATE LIMITED

Managing director

01/04/2011

18/05/2005

-

Active

NO

3

U73100MH2006PTC160020

ENALTEC LABS PRIVATE LIMITED

Managing director

23/12/2013

11/05/2007

-

Active

NO

4

U24233MH2007PTC171203

Pharma Serv Ventures Private Limited

Director

29/05/2007

29/05/2007

10/05/2010

Active

NO

5

U24232MH2007PTC173479

Getz Pharma Private Limited

Director

27/08/2007

27/08/2007

-

Active

NO

6

AAB-9559

GENLINK PHARMA LLP

Designated Partner

24/12/2013

24/12/2013

-

Active

NO

 

 

Name :

Mr. Susheel Koul

Designation :

Director

Address :

1601, Bloomingdale, 16th Floor, Hiranandani Estate, GB Road, Thane, 400607, Maharashtra, India

Date of Birth/Age :

01.05.1965

Date of Appointment :

11.11.2008

DIN No.:

00925887

Other Directorship:

S.

No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24230MH2004PTC146489

PHARMA SERV SOLUTIONS PRIVATE LIMITED

Director

24/05/2004

24/05/2004

03/12/2009

Active

NO

2

U24230MH2005PTC153516

STANTECH PHARMACEUTICALS PRIVATE LIMITED

Director

26/05/2005

26/05/2005

07/11/2009

Active

NO

3

U24233MH2007PTC171203

Pharma Serv Ventures Private Limited

Director

07/11/2008

07/11/2008

10/05/2010

Active

NO

4

U73100MH2006PTC160020

ENALTEC LABS PRIVATE LIMITED

Director

11/11/2008

11/11/2008

-

Active

NO

5

U21098MH2012PTC230335

PRINTLINK PLATES PRIVATE LIMITED

Director

27/04/2012

27/04/2012

-

Active

NO

6

U29199TN2013PTC094218

BUDENBERG GAUGE PRIVATE LIMITED

Director

19/12/2013

19/12/2013

04/02/2014

Active

NO

7

AAB-9559

GENLINK PHARMA LLP

Designated Partner

24/12/2013

24/12/2013

-

Active

NO

 

 

Name :

Mr. Prabir Purkayastha

Designation :

Director

Address :

F - 9, Greenwood City, Sector - 46, Gurgaon-122001, Haryana, India

Date of Birth/Age :

01.11.1949

Date of Appointment :

15.03.2010

DIN No.:

01126088

Other Directorship:

S.

No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U74899DL1990PTC040900

SAGRIK PROCESS ANALYSTS PRIVATE LIMITED

Director

30/03/1992

30/03/1992

-

Active

NO

2

U72200DL1993PTC055269

STARTACUS SOFTWARE PRIVATE LIMITED

Director

17/09/1993

17/09/1993

-

Strike off

NO

3

U93090UR2001NPL026206

ARTISANS TECHNOLOGIES

Director

05/09/2001

05/09/2001

-

Dormant

NO

4

U73100MH2006PTC160020

ENALTEC LABS PRIVATE LIMITED

Director

30/09/2010

15/03/2010

-

Active

NO

5

L74899HR1985PLC034348

KLG SYSTEL LIMITED

Director

24/09/2011

17/01/2011

14/11/2012

Active

NO

6

U22130DL2014PTC270085

PG NEWSCLICK INDIA PRIVATE LIMITED

Director

07/08/2014

07/08/2014

-

Active

NO

 

 

Name :

Mr. Charles Richard Hirschkind

Designation :

Director

Address :

California, California, 94708, United States of America

Date of Birth/Age :

07.10.1957

Date of Appointment :

29.09.2012

DIN No.:

05116062

Other Directorship:

S.

No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U73100MH2006PTC160020

ENALTEC LABS PRIVATE LIMITED

Director

29/09/2012

09/11/2011

-

Active

NO

 

 

MAJOR SHAREHOLDERS

 

As on 11.09.2013

 

Names of Shareholders

No. of Shares

% of Holding

Scitech Limited

1083357

70.00

Anand Prafulchandra Shah

185718

12.00

Susheel Koul

185718

12.00

B.V. Siva Kumar

92857

6.00

Total

1547650

100.00

 

 

Equity Share Break up (Percentage of Total Equity)

 

As on 11.09.2013

 

Category

Percentage

Foreign holdings( Foreign institutional investor(s), Foreign companie(s) Foreign financial institution(s), Non-resident Indian(s) or Overseas Corporate bodies or Others

70.00

Directors or relatives of Directors

30.00

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturing and Trading in of Pharmaceuticals Products.

 

 

Products :

Product Description

Item Code No.:

Moxifloxacin Gydroc Gloride Mono Gydrate Ep

2934 9900

Montelukast Sodium

2993 4990

Rosuvastain Calcium

2942 0090

 

 

GENERAL INFORMATION

 

No. of Employees :

Information denied by management

 

 

Bankers :

·         State Bank of Mauritius Limited, 101, Raheja Centre, Free Journal Road, Nariman Point, Mumbai-400021, Maharashtra, India

·         Central Bank of India, 1st Floor, Bajaj Bhavan, Nariman Point, Mumbai-400021, Maharashtra, India

 

 

Facilities :

SECURED LOANS

31.03.2013

Rs. In Millions

31.03.2012

Rs. In Millions

Long Term Borrowings

 

 

Term Loan from Bank

 

 

ICICI Bank

15.900

31.800

Stale Bank of Mauritius

4.897

0.000

Vehicle loan from bank

0.000

0.697

Vehicle loan from other

0.205

0.334

Short Term Borrowings

 

 

Loans repayable on demand

 

 

From Banks

176.847

118.806

Total

197.849

151.637

 

Notes:

 

Long Term Borrowings

 

·         ICICI Bank

(Secured By charge on movable fixed assets of the Company (excluding assets financed by State Bank of Mauritius) and ari passu charge on immovable fixed assets of the company located at Plot No. N-61, Addl. MIDC, Ambernath, Thane, Maharashtra) The term loan IS guaranteed by (i) Mr. Anand Shah (ii) Mr. Susheel Koul, (iii) Dr. B.V. Sivakumar

 

Terms of Repayment: 51 equal monthly installment commencing from January 2011. Last installment due on March 2015

 

·         Stale Bank of Mauritius

(Secured By exclusive charge on movable fixed assets financed by the loan and pan passu charge on immovable fixed assets of the company located at Plot No. N-61, Addl. MIDC, Ambernath, Thane, Maharashtra)

(The term loan IS guaranteed by (I) Mr. Anand Shah (11) Mr. Susheel Koul (iii) Dr. B.V. Sivakumar)

 

·         Vehicle loan from bank

(Secured By hypothecation of vehicle financed by respective lenders.)  Terms of Repayment : Repayable as per respective EM1 schedules

 

·         Vehicle loan from others

(Secured By hypothecation of vehicles financed by respective lenders.)

 

Short Term Borrowings

 

(Secured by way of

 

(i)       hypothecation of current assets of the Company on a pari passu basis

(ii)     Second charge on movable fixed assets of the Company on pari passu basis

(iii)    Mortgage on immovable fixed asset of the Company located at Plot No. N-61, Addl. MIDC, Ambemath, Thane, Maharashtra on pari passu basis.)

 

(The borrowings are guaranteed by

 

(i)       Mr Anand Shah

(ii)     Mr. Susheel Koul

(iii)    Dr. B.V. Slvakumar

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Shankarial Jain and Associates

Chartered Accountant

Address :

12, Enginner Building, 265, Princess Street, Mumbai-400002, Maharashtra, India

Tel. No.:

91-22-22036623 / 22065739

Fax No.:

91-22-22086269

E-Mail :

info@sljainindia.com

PAN No.:

AACFS6967Q

 

 

Holding Company :

·         Scitech Limited

 

 

Enterprises where key management personnel are able to exercise significant influence :

 

·         Getz Pharma Research Private Limited

·         Getz Pharma Private Limited

 

 

 

CAPITAL STRUCTURE

 

As on 11.09.2013

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

1550000

Equity Shares

Rs.10/- each

Rs.15.500 Millions

283500

Preference Shares

Rs.10/- each

Rs.2.835 Millions

 

Total

 

Rs.18.335 Millions

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

1547650

Equity Shares

Rs.10/- each

Rs.15.477 Millions

 

 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2013

31.03.2012

31.03.2011

I.        EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

15.477

14.575

13.059

(b) Reserves & Surplus

280.968

210.899

152.900

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

296.445

225.474

165.959

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

73.741

58.753

50.179

(b) Deferred tax liabilities (Net)

0.000

6.186

11.395

(c) Other long term liabilities

42.558

58.714

25.338

(d) long-term provisions

4.203

2.493

2.353

Total Non-current Liabilities (3)

120.502

126.146

89.265

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

176.847

119.888

119.375

(b) Trade payables

186.920

168.578

196.706

(c) Other current liabilities

41.209

29.885

56.599

(d) Short-term provisions

11.050

8.733

3.506

Total Current Liabilities (4)

416.026

327.084

376.186

 

 

 

 

TOTAL

832.973

678.704

631.410

 

 

 

 

II.      ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

217.943

218.893

229.955

(ii) Intangible Assets

90.137

69.152

47.618

(iii) Capital work-in-progress

0.000

0.000

0.000

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.000

0.000

0.000

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

6.824

6.024

3.086

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

314.904

294.069

280.659

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

225.234

133.727

128.873

(c) Trade receivables

209.994

191.444

159.849

(d) Cash and cash equivalents

11.678

14.951

9.720

(e) Short-term loans and advances

69.681

43.057

50.554

(f) Other current assets

1.482

1.456

1.755

Total Current Assets

518.069

384.635

350.751

 

 

 

 

TOTAL

832.973

678.704

631.410

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2013

31.03.2012

31.03.2011

 

SALES

 

 

 

 

 

Income

844.677

676.067

615.944

 

 

Other Income

NA

3.936

5.73

 

 

TOTAL                                         (A)

NA

680.003

621.674

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of Materials Consumed

259.583

327.122

 

 

Purchase of Stock-in-trade

 

118.226

96.922

 

 

Changes in Inventories of finished goods, work-in-progress and stock-in-trade

 

0.052

-35.961

 

 

Employee Benefits Expenses

 

45.584

41.367

 

 

Other Expenses

 

163.553

128.279

 

 

TOTAL                                         (B)

NA

586.998

557.729

 

 

 

 

 

 

PROFIT/(LOSS) BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

NA

93.005

63.945

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

NA

32.436

32.449

 

 

 

 

 

 

PROFIT/(LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                (E)

NA

60.569

31.496

 

 

 

 

 

Less

DEPRECIATION/ AMORTISATION                     (F)

NA

20.217

14.449

 

 

 

 

 

 

PROFIT/(LOSS) BEFORE TAX (E-F)                   (G)     

66.928

40.352

17.047

 

 

 

 

 

Less

TAX                                                                  (H)

8.219

3.587

9.937

 

 

 

 

 

 

PROFIT/(LOSS) AFTER TAX (G-H)                    (I)

58.709

36.765

7.110

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

61.363

24.598

17.488

 

 

 

 

 

 

BALANCE CARRIED TO THE B/S

120.072

61.363

24.598

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export Earnings

598.420

536.998

411.997

 

TOTAL EARNINGS

598.420

536.998

411.997

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

289.249

117.608

136.434

 

TOTAL IMPORTS

289.249

117.608

136.434

 

 

 

 

 

 

Earnings Per Share (Rs.)

 

 

 

 

Basic

46.98

29.46

6.95

 

Diluted

46.98

27.76

6.59

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2013

31.03.2012

31.03.2011

PAT / Total Income

(%)

NA

5.41

1.14

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

7.92

5.97

2.77

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

8.03

5.95

2.70

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.23

0.18

0.10

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

0.85

0.79

1.02

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.25

1.18

0.93

 


 

FINANCIAL ANALYSIS

[all figures are in Rupees Millions]

 

DEBT EQUITY RATIO

 

Particular

31.03.2011

31.03.2012

31.03.2013

 

Rs. In Millions

Rs. In Millions

Rs. In Millions

Share Capital

13.059

14.575

15.477

Reserves & Surplus

152.900

210.899

280.968

Net worth

165.959

225.474

296.445

 

 

 

 

long-term borrowings

50.179

58.753

73.741

Short term borrowings

119.375

119.888

176.847

Total borrowings

169.554

178.641

250.588

Debt/Equity ratio

1.022

0.792

0.845

 

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2011

31.03.2012

31.03.2013

 

Rs. In Millions

Rs. In Millions

Rs. In Millions

Sales

615.944

676.067

844.677

 

 

9.761

24.940

 

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2011

31.03.2012

31.03.2013

 

Rs. In Millions

Rs. In Millions

Rs. In Millions

Sales

615.944

676.067

844.677

Profit

7.110

36.765

58.709

 

1.15%

5.44%

6.95%

 

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

-----------

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

----------

22]

Litigations that the firm / promoter involved in

----------

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

----------

26]

Buyer visit details

----------

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

Yes

UNSECURED LOANS:

 

Particulars

31.03.2013

Rs. In Millions

31.03.2012

Rs. In Millions

Long Term Borrowings

 

 

From Banks

(Terms of Repayment: 36 equal monthly Installment commencing from December 2010 and ending December 2013)

0.000

0.398

Other loans and advances

52.739

25.524

Short Term Borrowings

 

 

Loans repayable on demand

0.000

1.082

Total

52.739

27.004

 

Notes:

 

Terms of Repayment: 12 equal monthly installment, commencing from September 2011. Last installment due on August, 2012.

 

 

REVIEW OF OPERATIONS:

 

During the year, the Company has earned Rs.844.677 Millions from Operations as compared to Rs.676.067 Millions during the previous Financial Year, thereby recording a growth of 25% in Revenue from Operations.

 

The Profit after Tax grew by almost 60% in the year as compared to the Previous Year.

 

 

INDEX OF CHARGE:

 

Sr. No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

Charge Holder

Address

Service Request Number (SRN)

1

10490646

20/06/2014 *

365,000,000.00

UNION BANK OF INDIA

Andheri East Branch,, Mayani Manor,Sir M.V. Road, Mumbai, Maharashtra - 400069, India

C11061132

2

10348816

22/11/2011

464,000.00

Cholamandalam Investment And Finance Company Limited

Dare House, No. 2 N S C Bose Road, Parrys, Chennai, Tamil Nadu - 600001, India

B32726085

*Date of modification Charges

 

 


FIXED ASSETS:

 

·         Land

·         Building

·         Plant and Machinery

·         Computer

·         Vehicles

·         Furniture and Fixture

 

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.60.61

UK Pound

1

Rs.100.49

Euro

1

Rs.79.56

 

 

INFORMATION DETAILS

 

Information Gathered by :

PRT

 

 

Analysis Done by :

KAR

 

 

Report Prepared by :

VNT


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

6

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILIRY

1~10

5

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

5

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

 

 

 

TOTAL

 

48

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NB

NEW BUSINESS

 

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.